Sonic Healthcare Limited (SKHHY)

Market Cap	6.64B -17.9%
Revenue (ttm)	6.95B +11.7%
Net Income	359.79M -1.1%
EPS	0.74 -2.7%
Shares Out	n/a
PE Ratio	18.47
Forward PE	14.55
Dividend	0.66 (4.72%)
Ex-Dividend Date	Mar 5, 2026

Volume	n/a
Open	13.33
Previous Close	13.77
Day's Range	13.33 - 13.33
52-Week Range	12.96 - 19.25
Beta	0.57
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 3, 2026

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1934
• Employees: 45,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: SKHHY

Financial Performance

In fiscal year 2025, Sonic Healthcare's revenue was 9.65 billion, an increase of 7.56% compared to the previous year's 8.97 billion. Earnings were 513.60 million, an increase of 0.49%.

Financial numbers in AUD